Management of idiopathic pulmonary fibrosis in France: A survey of 1244 pulmonologists

Summary Background The present survey coordinated by the French expert centres for rare pulmonary diseases investigated French pulmonologists' current diagnostic and therapeutic practice for idiopathic pulmonary fibrosis (IPF). Methods From December 7, 2011 to February 18, 2012, all French pulm...

Full description

Saved in:
Bibliographic Details
Published in:Respiratory medicine 2014-01, Vol.108 (1), p.195-202
Main Authors: Cottin, V, Cadranel, J, Crestani, B, Dalphin, J.C, Delaval, P, Israel-Biet, D, Kessler, R, Reynaud-Gaubert, M, Valeyre, D, Wallaert, B, Bouquillon, B, Cordier, J.F
Format: Article
Language:English
Subjects:
Administration, Oral
Drug therapy
Early Diagnosis
Family physicians
France
Glucocorticoids - therapeutic use
Health Care Surveys
Hospitals
Human health and pathology
Humans
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis - diagnosis
Idiopathic Pulmonary Fibrosis - drug therapy
Idiopathic Pulmonary Fibrosis - physiopathology
Life Sciences
Lung diseases
Management
Medical practices
Physicians
Pirfenidone
Practice Guidelines as Topic
Pulmonary Diffusing Capacity
Pulmonary fibrosis
Pulmonary Medicine
Pulmonary/Respiratory
Pulmonology and respiratory tract
Studies
Survey
Surveys and Questionnaires
Treatment Outcome
Vital Capacity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Background The present survey coordinated by the French expert centres for rare pulmonary diseases investigated French pulmonologists' current diagnostic and therapeutic practice for idiopathic pulmonary fibrosis (IPF). Methods From December 7, 2011 to February 18, 2012, all French pulmonologists ( n  = 2608) were contacted. Those who reported following up at least one IPF patient ( n  = 509) were administered a 26-item questionnaire by phone or e-mail. Results 509 pulmonologists (41% of responders, 20% of French pulmonologists) were involved in the management of IPF patients. Of those, 36% discussed the cases with radiologists and pathologists. Out of 406 community pulmonologists practicing outside of reference or competence (e.g. expert) centres, 141 (35%) indicated referring patients to those centres. The 2011 international guidelines for IPF were known by 67% of pulmonologists involved in IPF, 84% of whom considered them appropriate for practice. About 58% of patients were diagnosed with mild to moderate IPF as defined by percentage predicted forced vital capacity ≥50% and percentage predicted diffusing capacity of the lung for carbon monoxide ≥35%. Management resulted from multidisciplinary discussion in 36% of the cases. By the end of December 2011, 49% of patients with mild to moderately severe IPF were treated with oral corticosteroids, and 27% received no treatment. Conclusions Despite correct awareness of international IPF guidelines, modalities of multidisciplinary discussion and of early diagnosis and management need to be improved through the network of expert centres.
ISSN:0954-6111
1532-3064
DOI:10.1016/j.rmed.2013.11.017